Terveystalo renews preventive healthcare - Nightingale Health's modern health technology to be used in occupational health
Terveystalo and Finnish health technology company Nightingale Health are expanding their strategic cooperation. As the next concrete step in the cooperation, Terveystalo will modernise preventive healthcare by integrating Nightingale's blood analysis technology into occupational health check-ups during the coming autumn. By using modern technology, Terveystalo's Occupational Health will be able to detect the working age population's disease risks for several common chronic diseases, prevent illnesses and thus significantly reduce the burden on healthcare in the future.
As the largest provider of occupational health services in Finland, Terveystalo looks after the health of more than 700,000 Finns of working age. By integrating the blood analysis developed by Nightingale into occupational health check-ups, Terveystalo is offering more and more people of working age a view of their personal susceptibility to common diseases and support for lifestyle changes to reduce this susceptibility.
– Many chronic diseases, such as diabetes and cardiovascular disease, have a direct impact on work and functional capacity, require regular monitoring and place a burden on the healthcare system. However, a very high proportion of common diseases in people of working age are preventable. We need innovative solutions for effective preventive care, and the closer collaboration between Terveystalo and Nightingale provides that. By being better able to prevent the outbreak of public health diseases, we will reduce their negative impact on our economy while promoting the health and well-being of each individual, says Marja-Leena Tuomola, Commercial Director at Terveystalo.
Nightingale's blood analysis technology is one of the world's most widely used next-generation tools for medical research and preventive health. It has already measured around 2 million blood samples. Its performance and benefits have been demonstrated in more than 450 peer-reviewed scientific publications and it has passed European healthcare regulatory requirements.
– Nightingale's mission is to bring disease prevention and a healthier life within everyone's reach. We are delighted that we can build a healthier future for Finns in cooperation with Terveystalo. Our goal is to support Terveystalo's professionals in that they can offer their customers even better preventive health information and support them on their journey towards a healthier life, says Teemu Suna, CEO of Nightingale Health.
Significant impact on the health of the Finnish population
Terveystalo's medical experts have chosen the eight most important chronic diseases to be surveyed: heart attack, stroke, type 2 diabetes, liver fibrosis and cirrhosis, chronic kidney failure, COPD, lung cancer and alcoholic liver disease. Nightingale Health's blood analysis technology brings even more clarity to the work of an occupational health professional. At the same time, it offers an even better opportunity to focus on the customer at the reception, when, to support the clinical work, the professional already has an individual assessment based on metabolic markers of the person's risk of falling ill with the chronic diseases in question before the reception.
– We know from the beginning that the patient's own commitment and motivation play a great importance in the success of a lifestyle change. Nightingale Health's wide-ranging identification of disease risks significantly increases the effectiveness and benefits of preventive health care for both health professionals and customers, because thanks to modern health technology, we can motivate people to change their lifestyle by concretizing their susceptibility to disease. The positive changes observed during the follow-up certainly act as a motivator to maintain new lifestyles, says Jukka Pitkänen, Chief Medical Officer, Terveystalo Occupational Health.
A unique view of health to support preventive action
The Finnish working population is aging at a record pace. The younger working age groups are smaller, which is why it is important to manage to extend working careers and avoid early retirement. In addition, as the work has become physically lighter, Finns' general fitness has decreased and thus increased the susceptibility to falling ill with national diseases.
– As more and more people of working age find out their susceptibility to illness as part of occupational health inspections, we can create an even more comprehensive picture of the health and well-being of the organization's employees. This, in turn, helps employers plan the most effective health-promoting measures for the entire organization and implement targeted preventive occupational health activities based on verified information, adds Pitkänen.
New service available for occupational health customers in January 2024
The new agreement signed between Terveystalo and Nightingale is a continuation of the cooperation that started in April 2021, with which Terveystalo has the exclusive right to act as Nightingale's private healthcare partner in Finland. Terveystalo will develop its occupational health services during the fall of 2023 and integrate Nightingale's blood analysis as part of preventive work ability management. The new service will be available to Terveystalo's occupational health customers throughout Finland in January 2024.
Read more occupational health news
As the largest provider of occupational health services in Finland, Terveystalo takes care of the health of more than 700 000 Finns of working age. By integrating the blood analysis developed by Nightingale into occupational health checks, Terveystalo offers more and more working-age people a view of their personal susceptibility to common diseases and support for lifestyle changes to reduce this susceptibility.
– Many chronic diseases, such as diabetes and cardiovascular diseases, have a direct impact on work and functional capacity and require regular monitoring, placing a strain on the health care system. However, a very high proportion of common diseases among working-age people are preventable. We need innovative solutions for effective preventive care, and the closer cooperation between Terveystalo and Nightingale provides that. By being better able to prevent the outbreak of public health diseases, we will reduce their negative impact on our economy while promoting the health and well-being of every individual, says Marja-Leena Tuomola, Commercial Director at Terveystalo.
Nightingale's blood analysis technology is one of the world's most widely used next-generation medical research and preventive health tools. It has already measured around 2 million blood samples. Its performance and benefits have been demonstrated in more than 450 peer-reviewed scientific publications and it has passed European healthcare regulatory requirements.
– Nightingale's mission is to bring disease prevention and healthier living to everyone. We are excited to be building a healthier future for Finns in partnership with Terveystalo. Our goal is to support Terveystalo's professionals in providing better preventive health information to their customers and supporting them on their journey towards a healthier life, says Teemu Suna, CEO of Nightingale Health.
Significant impact on the health of the Finnish population
Medical experts at Terveystalo have selected eight of the most important chronic health diseases for the survey: myocardial infarction, cardiovascular disease, type 2 diabetes, liver fibrosis and cirrhosis, chronic kidney disease, COPD, lung cancer and alcoholic liver disease. Nightingale Health's blood analysis technology brings greater clarity to the work of the occupational health professional. At the same time, it provides an even better opportunity to focus on the client in the practice, as the clinical work is supported by a personalised assessment of the individual's risk of developing these diseases, based on metabolic markers, prior to the appointment.
– We already know that patient engagement and motivation play a major role in the success of lifestyle change. Nightingale Health's comprehensive disease risk identification significantly increases the effectiveness and benefits of preventive healthcare for both healthcare professionals and clients, as modern health technology enables us to motivate people to make lifestyle changes by making disease risk more tangible. The positive changes observed during monitoring will certainly act as a motivator to maintain new lifestyles, says Jukka Pitkänen, Chief Medical Officer, Occupational Health at Terveystalo.
A unique view of health to support preventive actions
The Finnish working population is ageing at a record rate. Younger working age groups are smaller, making it important to succeed in extending working lives and avoiding early retirement. In addition, as work has become less physically demanding, the general fitness of Finns has declined, increasing the risk of contracting common chronic diseases.
– As more people of working age find out about their own susceptibility to illness as part of an occupational health check, we can build up a more comprehensive picture of the health and well-being of an organisation's employees. This in turn will help employers to design the most effective health promotion measures for the whole organisation and to implement targeted preventive occupational health activities based on the verified information, adds Pitkänen.
New service available to occupational health customers in January 2024
The new agreement between Terveystalo and Nightingale is a continuation of the cooperation that started in April 2021, giving Terveystalo the exclusive right to act as Nightingale's private healthcare partner in Finland. During autumn 2023, Terveystalo will develop its occupational health services and integrate Nightingale's blood analysis into preventive work ability management. The new service will be available to Terveystalo's occupational health customers throughout Finland in January 2024.